NextGen Healthcare, Inc. (NXGN) — Financial statements
Income statement, balance sheet, and cash flow for NextGen Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 653↑9.5% | 596↑7.1% | 557↑3.1% | 540↑2.1% | 529 | |
| Cost of Revenue | 342↑15.8% | 295↑7.3% | 275↑3.0% | 267↑8.4% | 247 | |
| Gross Profit | 311↑3.4% | 301↑6.9% | 281↑3.2% | 273↓3.4% | 282 | |
| Operating Expenses | ||||||
| R&D Expenses | 82↑7.4% | 77↑1.5% | 76↓9.4% | 83↑2.8% | 81 | |
| General & Administrative Expenses | 213↑5.1% | 203↑14.9% | 177↑11.0% | 159↑1.6% | 157 | |
| Selling & Marketing Expenses | 10↑51.5% | 7↑73.8% | 4↓35.4% | 6↓26.5% | 8 | |
| SG&A Expenses | 223↑6.6% | 210↑16.1% | 181↑9.3% | 165↑0.2% | 165 | |
| Other Expenses | 4↑4.0% | 4↓20.8% | 4↑7.4% | 4↓4.6% | 4 | |
| Operating Expenses | 309↑6.7% | 290↑11.3% | 260↑3.1% | 253↑1.0% | 250 | |
| Total Costs & Expenses | 651↑11.3% | 585↑9.2% | 536↑3.0% | 520↑4.7% | 497 | |
| Operating Results | ||||||
| Operating Income | 16↑45.8% | 11↓46.7% | 21↓1.9% | 21↓32.7% | 32 | |
| Depreciation & Amortization | 37↓13.3% | 42↓14.0% | 49↑1087.9% | 4↓24.2% | 5 | |
| EBITDA | 48↓10.1% | 53↓23.8% | 70↑175.6% | 25↓32.3% | 38 | |
| EBIT | 11↓5.1% | 11↓42.8% | 20↓4.0% | 20↓36.6% | 32 | |
| Interest & Other Income | ||||||
| Net Interest Income | -3↓97.2% | -1↑59.8% | -3↓104.7% | -2↑34.6% | -3 | |
| Interest Income | 4↑3405.9% | 0.10↑165.8% | 0.04↓85.2% | 0.26↑18.5% | 0.22 | |
| Interest Expense | 6↑320.1% | 1↓57.4% | 4↑79.8% | 2↓30.5% | 3 | |
| Non-Operating Income | -14↓39002.7% | -0.04↓242.3% | 0.03↑102.4% | -1↓128.2% | -0.48 | |
| Other Income / Expenses | 8↑237.4% | -6↑42.2% | -10↑31.4% | -15↓542.6% | -2 | |
| Income Before Tax | 4↓17.2% | 5↓44.0% | 9↑117.8% | 4↓85.5% | 29 | |
| Income Tax Expense | 7↑94.5% | 4↑1590.8% | -0.24↑92.6% | -3↓167.6% | 5 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -3↓264.0% | 2↓83.0% | 10↑26.9% | 7↓69.4% | 24 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -3↓264.0% | 2↓83.0% | 10↑26.9% | 7↓69.4% | 24 | |
| Bottom-Line Net Income | -3↓264.0% | 2↓83.0% | 10↑26.9% | 7↓69.4% | 24 | |
| EPS (Basic) | -0.04↓300.0% | 0.02↓85.7% | 0.14↑27.3% | 0.11↓71.1% | 0.38 | |
| EPS (Diluted) | -0.04↓298.0% | 0.02↓85.7% | 0.14↑27.3% | 0.11↓71.1% | 0.38 | |
| Weighted Average Shares | 66↓1.5% | 67↑0.9% | 67↑1.9% | 65↑1.6% | 64 | |
| Weighted Average Diluted Shares | 67↓1.2% | 68↑1.4% | 67↑1.9% | 66↑1.6% | 65 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.